Literature DB >> 1625055

Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast.

D J Allan1, A Howell, S A Roberts, G T Williams, R J Watson, J D Coyne, R B Clarke, I J Laidlaw, C S Potten.   

Abstract

The aims of this study in 227 premenopausal women were (a) to determine the mitotic index (MI), the thymidine labelling index (LI), and the apoptotic index (AI) within the epithelial cells of histologically 'normal' human breast biopsy material removed away from the site of either a fibroadenoma or a carcinoma; and (b) to relate differences in the kinetic indices of the 'normal' epithelium to the pathology in the same breast diagnosed as fibroadenoma alone (125 patients), fibroadenoma with accompanying mild fibrocystic change (79 patients), or carcinoma (23 patients). Ratios of the average indices (AI/MI, AI/LI, MI/LI) were also calculated to minimize uncertainties related to the total cell population counted, the denominator in the LI, MI, and AI. All indices and ratios of indices were corrected for age, averaged over the cycle, and expressed as log-transformed values for analysis. Significant (P less than 0.001) reductions in AI and in apoptosis relative to mitosis (reduced AI/MI) were found in 'normal' epithelium from breasts having fibrocystic change (AI = 0.17 +/- 0.02; AI/MI = 1.01 +/- 0.18) and carcinoma (AI = 0.19 +/- 0.04; AI/MI = 0.88 +/- 0.29), compared with breast with fibroadenoma alone (AI = 0.27 +/- 0.03; AI/MI = 1.29 +/- 0.39). In the absence of significant differences in MI and LI between the 'normal' tissue groups, this finding raises the possibility that reduced epithelial cell apoptosis might be causally associated with the development of fibrocystic change and with an increased risk of development of carcinoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625055     DOI: 10.1002/path.1711670106

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  21 in total

Review 1.  Studies of apoptosis in breast cancer.

Authors:  M Parton; M Dowsett; I Smith
Journal:  BMJ       Date:  2001-06-23

Review 2.  Hormone-induced protection against breast cancer.

Authors:  Lakshmi Sivaraman; Daniel Medina
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

3.  Apoptosis in human gastric mucosa, chronic gastritis, dysplasia and carcinoma: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling.

Authors:  M Ishida; Y Gomyo; S Tatebe; S Ohfuji; H Ito
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

4.  Tumor-necrosis-factor-induced fibroblast growth factor-1 acts as a survival factor in a transformed endothelial cell line.

Authors:  J A Maier; D Morelli; S Ménard; M I Colnaghi; A Balsari
Journal:  Am J Pathol       Date:  1996-09       Impact factor: 4.307

Review 5.  Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer.

Authors:  David N Danforth
Journal:  Breast Cancer (Auckl)       Date:  2016-08-17

Review 6.  Chemoprevention of breast cancer: implications for postmenopausal women.

Authors:  Carol J Fabian; Bruce F Kimler
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

7.  bcl-2 protein in invasive ductal breast carcinomas.

Authors:  J Hurlimann; B Larrinaga; D L Vala
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Apoptosis is inversely related to necrosis and determines net growth in tumors bearing constitutively expressed myc, ras, and HPV oncogenes.

Authors:  M J Arends; A H McGregor; A H Wyllie
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  Detection of DNA strand breaks associated with apoptosis in human brain tumors.

Authors:  S Nakagawa; T Shiraishi; S Kihara; K Tabuchi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

10.  Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma.

Authors:  I Okayasu; M Saegusa; M Fujiwara; Y Hara; N R Rose
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.